Changes for page Post-market surveillance and market acceptance testing

Summary

• Page properties (2 modified, 0 added, 0 removed)

Details

Page properties

Author

...	...	@@ -1,1 +1,1 @@
1		-XWiki.Sarantis
	1	+XWiki.evdokimosk

Content

...	...	@@ -1,24 +1,22 @@
1		-(% class="western" lang="en-GB" style="text-align:justify" %)
2		-(% lang="en-US" %)**Description:** Post-market surveillance is a “real world” test of medical innovations in patient subgroups. It is a practice of monitoring the safety of a medical innovation after it has been released on the market. Market acceptance testing focuses on collecting market feedback for the next revision development and tracking the solution performance in real competitive market conditions.
	1	+**Description:** Post-market surveillance is a “real world” test of medical innovations in patient subgroups. It is a practice of monitoring the safety of a medical innovation after it has been released on the market. Market acceptance testing focuses on collecting market feedback for the next revision development and tracking the solution performance in  real competitive market conditions.
3	3
4		-(% class="western" lang="en-GB" style="text-align:justify" %)
5		-(% lang="en-US" style="line-height:106%" %)**R&D service category-ies: **(% style="line-height:106%" %)Testing and validation, Market and competitor intelligence services
	3	+**R&D service categories: **Testing and validation, Market and competitor intelligence services
6	6
7		-(% class="western" lang="en-GB" style="text-align:justify" %)
8		-(% lang="en-US" style="line-height:106%" %)**Key **(% style="line-height:106%" %)**characteristics**(% lang="en-US" %)** in Living Lab context:**
	5	+**Key characteristics in living lab context:**
9	9
10		-* (% lang="en-US" %)Usually within a clinical or community research context (within the context of specific projects/the products that come out as research outcomes) and not as a standalone service.
11		-* (% lang="en-US" %)As normal customer feedback collection and health promotion, for continuum improvement of the tool
	7	+* Usually within a clinical or community research context (within the context of specific projects/the products that come out as research outcomes) and not as a standalone service.
12	12
13		-(% class="western" lang="en-GB" style="text-align:justify" %)
14		-(% lang="en-US" style="line-height:106%" %)**Objectives:**
	9	+* As normal customer feedback collection and health promotion, for continuum improvement of the tool
15	15
16		-* (% lang="en-US" style="line-height:106%" %)Monitoring the safety of a medical innovation after it has been released on the market,
17		-* (% lang="en-US" style="line-height:106%" %)Evaluate social impact,
18		-* (% lang="en-US" style="line-height:106%" %)Identify new opportunities for business and research
	11	+**Objectives:**
19	19
20		-(% class="western" lang="en-GB" style="text-align:justify" %)
21		-(% lang="en-US" style="line-height:106%" %)**Methods: **Survey, observation, interviews, helpdesk logs, technical logs, complain reports, pre and post measurement (long term), market studies
	13	+* monitoring the safety of a medical innovation after it has been released on the market,
	14	+* evaluate social impact,
	15	+* identify new opportunities for business and research
22	22
23		-(% class="western" lang="en-GB" style="text-align:justify" %)
24		-(% lang="en-US" style="line-height:106%" %)**Tools/online tools: **questionnaires, validated scientific scale/questionnaires, sensors
	17	+**Methods: **survey, observation, interviews, helpdesk logs, technical logs, complain reports, pre and post measurement (long term), market studies
	18	+
	19	+**Tools/online tools: **questionnaires, validated scientific scale/questionnaires, sensors
	20	+
	21	+
	22	+**Approved by** the VITALISE H2020 living labs' consensus report on 30/09/2021